Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Difamilast Ointment in Adult Atopic Dermatitis
NCT03908970Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Mar 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of difamilast in atopic dermatitis (AD), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Mar 2019; status: completed.
02
Drugs
difamilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03908970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03908970.